Robert E. Vann, Ph.D.

Affiliations: 
2004 Virginia Commonwealth University, Richmond, VA, United States 
Area:
drug abuse, behavioral pharmacology, rat/primate self administration
Google:
"Robert Vann"
Mean distance: 19.99 (cluster 19)
 

Parents

Sign in to add mentor
Patrick M. Beardsley grad student 2004 VCU
 (The role of dose, duration and pattern of nicotine exposure on the development of behavioral dependence.)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

McClay JL, Vunck SA, Batman AM, et al. (2015) Neurochemical Metabolomics Reveals Disruption to Sphingolipid Metabolism Following Chronic Haloperidol Administration. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology
Walentiny DM, Vann RE, Wiley JL. (2015) Phenotypic assessment of THC discriminative stimulus properties in fatty acid amide hydrolase knockout and wildtype mice. Neuropharmacology. 93: 237-42
Wiebelhaus JM, Grim TW, Owens RA, et al. (2015) Δ9-tetrahydrocannabinol and endocannabinoid degradative enzyme inhibitors attenuate intracranial self-stimulation in mice. The Journal of Pharmacology and Experimental Therapeutics. 352: 195-207
Wiley JL, Walentiny DM, Wright MJ, et al. (2014) Endocannabinoid contribution to Δ9-tetrahydrocannabinol discrimination in rodents. European Journal of Pharmacology. 737: 97-105
Adkins DE, McClay JL, Vunck SA, et al. (2013) Behavioral metabolomics analysis identifies novel neurochemical signatures in methamphetamine sensitization. Genes, Brain, and Behavior. 12: 780-91
McClay JL, Adkins DE, Vunck SA, et al. (2013) Large-scale neurochemical metabolomics analysis identifies multiple compounds associated with methamphetamine exposure. Metabolomics : Official Journal of the Metabolomic Society. 9: 392-402
Walentiny D, Vann R, Mahadevan A, et al. (2013) Novel 3-substituted rimonabant analogues lack Δ(9) -tetrahydrocannabinol-like abuse-related behavioural effects in mice. British Journal of Pharmacology. 169: 10-20
Tobey KM, Walentiny DM, Wiley JL, et al. (2012) Effects of the specific α4β2 nAChR antagonist, 2-fluoro-3-(4-nitrophenyl) deschloroepibatidine, on nicotine reward-related behaviors in rats and mice. Psychopharmacology. 223: 159-68
Vann RE, Walentiny DM, Burston JJ, et al. (2012) Enhancement of the behavioral effects of endogenous and exogenous cannabinoid agonists by phenylmethyl sulfonyl fluoride. Neuropharmacology. 62: 1019-27
Wiley JL, Matthew Walentiny D, Vann RE, et al. (2011) Dissimilar cannabinoid substitution patterns in mice trained to discriminate Δ(9)-tetrahydrocannabinol or methanandamide from vehicle. Behavioural Pharmacology. 22: 480-8
See more...